N2-iBu-5’-O-DMTr-2’-O-hexadecanyl guanosine 3’-CED phosphoramidite

Cat. No.: HY-154628: Data Sheet Handling Instructions Technical Support

N2-iBu-5’-O-DMTr-2’-O-hexadecanyl guanosine 3’-CED phosphoramidite is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.

For research use only. We do not sell to patients.

N2-iBu-5’-O-DMTr-2’-O-hexadecanyl guanosine 3’-CED phosphoramidite Chemical Structure

CAS No. : 2382942-32-5

Size	Price	Stock	Quantity
5 mg	USD 42	Get quote 3 - 4 weeks 2 - 3 weeks 2 - 3 weeks	2 - 3 weeks
10 mg	USD 64	Get quote 3 - 4 weeks 2 - 3 weeks 2 - 3 weeks	2 - 3 weeks
25 mg	USD 114	Get quote 3 - 4 weeks 2 - 3 weeks 2 - 3 weeks	2 - 3 weeks
50 mg	USD 177	Get quote 3 - 4 weeks 2 - 3 weeks 2 - 3 weeks	2 - 3 weeks
100 mg	USD 275	Get quote 3 - 4 weeks 2 - 3 weeks 2 - 3 weeks	2 - 3 weeks
250 mg	USD 494	Get quote 3 - 4 weeks 2 - 3 weeks 2 - 3 weeks	2 - 3 weeks
500 mg		Get quote
1 g		Get quote

Synthetic products have potential research and development risk.

or Bulk Inquiry

* Please select Quantity before adding items.

Customer Review

Based on 1 publication(s) in Google Scholar

Featured Recommendations

•Related Small Molecules:

Biological Activity
Purity & Documentation
References
Customer Review

Description	N2-iBu-5’-O-DMTr-2’-O-hexadecanyl guanosine 3’-CED phosphoramidite is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc^[1].
Molecular Weight	1080.34
Formula	C₆₀H₈₆N₇O₉P
CAS No.	2382942-32-5
SMILES	O=C1C2=C(N([C@H]3[C@H](OCCCCCCCCCCCCCCCC)[C@H](OP(N(C(C)C)C(C)C)OCCC#N)[C@@H](COC(C4=CC=CC=C4)(C5=CC=C(OC)C=C5)C6=CC=C(OC)C=C6)O3)C=N2)N=C(NC(C(C)C)=O)N1
Shipping	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation	Data Sheet (267 KB) Handling Instructions (2659 KB)
References	[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. [Content Brief]